Cited by 365Angiogenesis and VEGF in CancerAdipose Tissue and MetabolismAdipokines, Inflammation, and Metabolic Diseases

Paracrine Regulation of Angiogenesis and Adipocyte Differentiation During In Vivo Adipogenesis

Open access
Fukumura, Dai, Ushiyama, Akira, Duda, Dan G., Xu, Lei, Tam, Joshua, Krishna, V., Chatterjee, K., Garkavtsev, Igor +1 more·2003·Circulation Research

Abstract

With an increasing incidence of obesity worldwide, rational strategies are needed to control adipogenesis. Growth of any tissue requires the formation of a functional and mature vasculature. To gain mechanistic insight into the link between active adipogenesis and angiogenesis, we developed a model to visualize noninvasively and in real time both angiogenesis and adipogenesis using intravital microscopy. Implanted murine preadipocytes induced vigorous angiogenesis and formed fat pads in a mouse dorsal skin-fold chamber. The newly formed vessels subsequently remodeled into a mature network consisting of arterioles, capillaries, and venules, whereas the preadipocytes differentiated into adipocytes as confirmed by increased aP2 expression. Inhibition of adipocyte differentiation by transfection of preadipocytes with a peroxisome proliferator-activated receptor γ dominant-negative construct not only abrogated fat tissue formation but also reduced angiogenesis. Surprisingly, inhibition of angiogenesis by vascular endothelial growth factor receptor-2 (VEGFR2) blocking antibody not only reduced angiogenesis and tissue growth but also inhibited preadipocyte differentiation. We found that part of this inhibition stems from the paracrine interaction between endothelial cells and preadipocytes and that VEGF–VEGFR2 signaling in endothelial cells, but not preadipocytes, mediates this process. These findings reveal a reciprocal regulation of adipogenesis and angiogenesis, and suggest that blockade of VEGF signaling can inhibit in vivo adipose tissue formation. The full text of this article is available online at http://www.circresaha.org.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1161/01.res.0000099243.20096.fa

Cites

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Blockade through use of a VEGF-R2 antibody can further inhibit preadipocyte differentiation.

    “blockade through use of a VEGF-R2 antibody can further inhibit preadipocyte differentiation (82)”

    From Adipose tissue remodeling and obesity (2011) · cites this paper as [82]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

The citation lists haven’t been fetched yet

References 70 · Cited by 365

Research works printed but not linked: 1

  1. Gregoire FM, Smas CM, Sul HS. Understanding adipocyte differen- tiation. Physiol Rev. 1998;78:783-809.

Authors
Fukumura, D., Ushiyama, A., Duda, D. G., Xu, L., Tam, J., Krishna, V., Chatterjee, K., Garkavtsev, I., & Jain, R. K.
Affiliations
Harvard University (US)
Venue
Circulation Research
Published
2003-10-31
Volume
93
Issue
9
Pages
e88-97
ISSN
  • 0009-7330 (ISSN-L)
  • 1524-4571
OpenAlex
W2096599017
Cited by
365
References
70
Citations by year
2026: 5 · 2025: 7 · 2024: 11 · 2023: 11 · 2022: 7 · 2021: 13 · 2020: 16 · 2019: 15 · 2018: 9 · 2017: 13 · 2016: 9 · 2015: 16 · 2014: 22 · 2013: 30 · 2012: 16
FWCI
5.30
Type
journal article
Language
en
Open access
Locations
  • Circulation Research (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • Wellcome Trust
  • National Cancer Institute (T32CA073479, T32-CA73479, R24-CA85140, R01CA085140, R24CA085140, P01CA080124, P01-CA-80124)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
Keywords
adipogenesis, angiogenesis, paracrine signaling, preadipocytes, VEGF/VEGFR2 signaling, PPARγ, endothelial cells, adipose tissue formation, intravital microscopy, obesity, vascular remodeling
MeSH terms
Animals, Antibodies, Cell Differentiation, Genes, Dominant, Male, Transcription Factors, Diffusion Chambers, Culture, 3T3 Cells, Mice, SCID, Adipocytes, Receptors, Cytoplasmic and Nuclear, Neovascularization, Physiologic, Paracrine Communication, Stem Cell Transplantation, Vascular Endothelial Growth Factor Receptor-2, Vascular Endothelial Growth Factor A, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review